BeStock  
Stocks › Biotechnology › DNLI

Denali Therapeutics DNLI

US equityMarket cap rank #2440Biotechnology
$18.45 +$0.25 (+1.37%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $18.45 0.00%
Open$17.97
Prev close$18.20
Day range$17.92 – $18.85
Volume2.63M
Market cap$2.96B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership99.1%-5.40 pts vs. prior quarter
Institutions holding348-9 vs. prior quarter
Insider trades (recent)31 buys / 17 sellsNet buying
Short interest9.19% of floatDays to cover 9.9 · as of 30 Oct 2026
Short-sale volume share21.5%5-day average of daily volume

Short-sale volume as % of daily volume

9%16%24%31%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$7.21M (9 inflow days, 11 outflow days).

Net flow by order size, last 20 sessions

−$7.7MSuper+$496.2KBig−$1.4MMid+$898.7KSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 36.5% of shares outstanding.

Largest holders

  • T. Rowe Price Group, Inc.12.05%
  • BlackRock8.94%
  • Baillie Gifford6.94%
  • Temasek Holdings4.38%
  • Vanguard Portfolio Management, LLC4.22%
  • Vanguard Capital Management, LLC4.21%
  • State Street Global Advisors4.17%
  • UBS Asset Management3.53%

By investor type

  • Mutual Fund74.88%
  • Hedge Fund10.18%
  • VC/PE Fund7.80%
  • Individual/Insider2.96%
  • Public Company2.87%
  • Sovereign Wealth Fund1.77%
  • Private Company0.55%
  • Government Pension Fund0.52%

Reported short interest has fallen from 11.24% to 9.19% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +475,496 4.2%
Morgan Stanley Public Company 2026/Q3 +410,429 0.9%
Morgan Stanley Investment Management Inc. Mutual Fund 2026/Q3 +410,429 0.9%
BlackRock Mutual Fund 2026/Q3 +302,275 8.9%
Vanguard Portfolio Management, LLC Mutual Fund 2026/Q3 +281,353 4.2%
Renaissance Technologies Corp. Hedge Fund 2026/Q3 +218,700 0.1%
abrdn plc Mutual Fund 2026/Q3 +175,124 0.9%
Sector Gamma AS Mutual Fund 2026/Q3 +137,718 0.1%
T. Rowe Price Group, Inc. Mutual Fund 2026/Q3 +8,331,774 12.1%
Macquarie Investment Management Business Trust Mutual Fund 2026/Q3 +2,093,739 1.4%
BNPP Asset Management Holding Mutual Fund 2026/Q3 +1,071,130 0.7%
BlackRock Mutual Fund 2026/Q3 +991,979 8.8%
State Street Global Advisors Mutual Fund 2026/Q3 +777,303 4.4%
Holocene Advisors, LP Hedge Fund 2026/Q3 +709,796 2.4%
Goldman Sachs Asset Management, L.P. Mutual Fund 2026/Q3 +527,880 2.0%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
3 Sep 2026 Peter Chin Acting Chief Medical Officer & Head of Development Open Market Disposition -1,654 $22.29 204,538
1 Sep 2026 Nancy Thornberry Independent Director Automatic Disposition -11,439 $23.74 13,278
31 Aug 2026 Alexander Schuth Co-Founder, CFO, COO & Secretary Automatic Disposition -2,768 $23.44 667,269
11 Aug 2026 Ryan Watts Chief Executive Officer Other Disposition -32,220 – 2,232,302
10 Aug 2026 Alexander Schuth Co-Founder, CFO, COO & Secretary Open Market Disposition -2,857 $25.07 670,037
2 Jun 2026 Jay Flatley Independent Director Other Acquisition +6,408 – 6,408
2 Jun 2026 Jay Flatley Independent Director Other Derivative Acquisition +19,226 $19.66 19,226
2 Jun 2026 Julian Baker Independent Chairperson Other Acquisition +12,816 – 28,664
2 Jun 2026 Julian Baker Independent Chairperson Other Derivative Acquisition +19,226 $19.66 19,226
2 Jun 2026 David Schenkein Independent Director Other Acquisition +6,408 – 6,408
2 Jun 2026 David Schenkein Independent Director Other Derivative Acquisition +19,226 $19.66 19,226
2 Jun 2026 Peter Klein Independent Director Other Acquisition +6,408 – 6,408
2 Jun 2026 Peter Klein Independent Director Other Derivative Acquisition +19,226 $19.66 19,226
2 Jun 2026 Jennifer Cook Independent Director Other Acquisition +6,408 – 6,408
2 Jun 2026 Jennifer Cook Independent Director Other Derivative Acquisition +19,226 $19.66 19,226
2 Jun 2026 Timothy Van Hauwermeiren Other Acquisition +6,408 – 17,040
2 Jun 2026 Timothy Van Hauwermeiren Other Derivative Acquisition +19,226 $19.66 19,226
2 Jun 2026 Steve Krognes Independent Director Other Acquisition +6,408 – 6,408
2 Jun 2026 Steve Krognes Independent Director Other Derivative Acquisition +19,226 $19.66 19,226
2 Jun 2026 Nancy Thornberry Independent Director Other Acquisition +6,408 – 6,408

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 14,694,882 9.2% 9.9
15 Oct 2026 15,475,322 9.7% 8.1
30 Sep 2026 15,463,975 9.7% 7.6
15 Sep 2026 17,139,415 10.7% 12.0
31 Aug 2026 16,642,362 10.4% 17.5
14 Aug 2026 17,959,465 11.2% 12.4

Discussion

No comments yet — be the first to weigh in on DNLI.

Sign in to join the discussion.

Scroll to Top